BioGenCell Competitors and Similar CompaniesClear all
Carmot Therapeutics's competitors and similar companies include glyscend, Fractyl Health and Orgenesis.
 Carmot Therapeutics Carmot Therapeutics is a clinical-stage biotechnology company focused on the discovery of disease-modifying therapies in metabolic disease and cancer. |  Fractyl Health Fractyl Health (formerly known as Fractyl Laboratories) is a metabolic therapeutics company that develops therapies for treating type 2 diabetes (T2D) and obesity. |  Orgenesis Orgenesis focuses on a novel therapeutic treatment for diabetes by correcting malfunctioning organs with new functional tissues. | ||
Founding Date | Founding Date 2008 | Founding Date 2014 | Founding Date 2010 | Founding Date 2008 |
Type | Type Subsidiary | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Berkeley, US HQ | Locations Baltimore, US HQ Lowell, US | Locations Burlington, US HQ | Locations Germantown, US HQ Aye, BE Ness Ziona, IL Suwon Si, KR |
Employees | Employees 109% decrease | Employees 9 | Employees 88 | Employees 524% decrease |
Financial | ||||
Net income | Net income ($38.8m) (FY, 2022) | Net income N/A | Net income ($141m) (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 74.8m | Total funding raised $ 21m | Total funding raised $ 190.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
glyscend
HQ
Baltimore, US
Employees
9
glyscend is a company that develops a method of treating metabolic diseases.
View companyFractyl Health
HQ
Burlington, US
Employees
88
Fractyl Health (formerly known as Fractyl Laboratories) is a metabolic therapeutics company that develops therapies for treating type 2 diabetes (T2D) and obesity.
View companyOrgenesis
HQ
Germantown, US
Employees
52↓ 4% decrease
Orgenesis focuses on a novel therapeutic treatment for diabetes by correcting malfunctioning organs with new functional tissues.
View company